TP53 and head and neck cancer: Abramowicz et al. [53] showed that in a p53-wildtype Human Papillomavirus (HPV)- associated head and neck cancer cell line, EVs released by irradiated cells had increased levels of proteins, such as CD63 and CD81, whereas other surface protein levels remained unchanged (i.e., CD9 and TSG101).